Guardian Pharmacy Services (GRDN) Liabilities and Shareholders Equity (2023 - 2026)

Guardian Pharmacy Services has disclosed Liabilities and Shareholders Equity across 4 years of filings, most recently posting $443.6 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 24.48% year-over-year to $443.6 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 23.11% YoY), while the FY2025 annual figure was $412.7 million, up 28.63% from the prior year.
• Liabilities and Shareholders Equity came in at $443.6 million for Q2 2026 at Guardian Pharmacy Services, up from $426.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $443.6 million in Q2 2026 to a low of $271.2 million in Q4 2023.
• Average Liabilities and Shareholders Equity over 4 years is $367.1 million, with a median of $356.3 million recorded in 2025.
• The largest YoY upside for Liabilities and Shareholders Equity was 28.63% in 2025 against a maximum downside of 12.07% in 2025.
• Over 4 years, Liabilities and Shareholders Equity stood at $271.2 million in 2023, then grew by 18.31% to $320.8 million in 2024, then gained by 28.63% to $412.7 million in 2025, then increased by 7.49% to $443.6 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $443.6 million in Q2 2026, $426.9 million in Q1 2026, and $412.7 million in Q4 2025.